E-viri
PDF
Recenzirano
Odprti dostop
-
Arepally, Gowthami M.; Ortel, Thomas L.
Blood, 07/2021, Letnik: 138, Številka: 4Journal Article
The development of vaccines to fight COVID-19 has been a remarkable medical achievement. However, this global immunization effort has been complicated by a rare vaccine-related outcome characterized by thrombocytopenia and thrombosis in association with platelet-activating anti–platelet factor 4 antibodies. In this Spotlight, we will discuss the recently described complication of vaccine-induced immune thrombotic thrombocytopenia (VITT) occurring in response to certain COVID-19 vaccines. Although information about this clinical condition is rapidly evolving, we will summarize our current understanding of VITT. Display omitted
